Heterogeneous red–white discoloration of the nail bed and distal onycholysis in a patient with COVID‐19

Demir, Betül; Yüksel, Esma; Çiçek, Demet; Turkoglu, Sedatcan

doi:10.1111/jdv.17347

Cited by 10 publications

(12 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Interestingly, ten COVID‐19 patients were reported to have ungual changes 6,26,34–41 : The individuals affected were 6 women and 4 men. Transverse orange lesions 35 , the red half‐moon sign 34,36 , Beau lines 26,37,38 , onychomadesis 39 , retronychia 41 , Terry’s nail‐like lesions 40 , and transverse leukonychia 6 were described to appear after the SARS‐CoV‐2 infection.…”

Section: Resultsmentioning

confidence: 99%

“…Shanshal 33 Interestingly, ten COVID-19 patients were reported to have ungual changes 6,26,[34][35][36][37][38][39][40][41] : The individuals affected were 6 women and 4 men. Transverse orange lesions 35 , the red half-moon sign 34,36 , Beau lines 26,37,38 , onychomadesis 39 , retronychia 41 , Terry's nail-like lesions 40 , and transverse leukonychia 6 to disease onset was heterogeneous: For instance, the latency period was 16 weeks in the case of transverse orange lesions and 45 days in the case of transverse leukonychia.…”

Section: Re Sultsmentioning

confidence: 99%

See 1 more Smart Citation

Hair and nail manifestations of COVID‐19

Tammaro

Adebanjo

Parisella

et al. 2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Emerging literature evidence shows that the manifestations of the coronavirus disease 2019 (COVID‐19), which is the disease caused by SARS‐CoV‐2, encompass alterations of the pulmonary, cardiovascular, gastrointestinal, and neurological system. Moreover, hematologic and dermatologic manifestations have been documented. The aim of this review is to summarize the dermatologic manifestations of COVID‐19 involving the hair and nails in a narrative way. A total of 1136 patients have been reported to have de novo hair loss following COVID‐19. Notably, 958 patients experienced telogen effluvium (TE) (female/male ratio = 3,86:1), two female patients experienced anagen effluvium, and 176 people had alopecia areata (female/male ratio of 19:3). Ten patients were reported to have ungual changes following the infection with the novel coronavirus: The individuals affected were 6 women and 4 men. COVID‐19 can be associated with hair and ungual manifestations. This review summarizes the evidence regarding the hair and ungual manifestations of COVID‐19, which could be harnessed to better understand the clinical implications and pathophysiology of this disease that has been burdening society globally since December 2019.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Re Sultsmentioning

confidence: 99%

Hair and nail manifestations of COVID‐19

Tammaro

Adebanjo

Parisella

et al. 2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

“…27,28 Another late manifestation of COVID-19 disease is a heterogeneous red-white discoloration of the nail bed with distal onycholysis. 29…”

Section: Beau's Lines and Onychomadesismentioning

confidence: 99%

Nails and COVID ‐19 – A comprehensive review of clinical findings and treatment

Wollina

Kanitakis

Baran

2021

Dermatologic Therapy

View full text Add to dashboard Cite

The SARS‐CoV‐2 infection, responsible for COVID‐19, has raised the interest for infection‐associated muco‐cutaneous symptoms. While dermatologic symptoms in general gained an increasing awareness, affection of the nail organ has been mentioned only recently. We provide a narrative review on COVID‐19 manifestation on the nail organ and add symptoms induced by personal protective measures and SARS‐CoV‐2 vaccination. Available treatment options are discussed.

show abstract

“…Demir et al reported heterogeneous red-white discoloration of nail bed along with onycholysis after 1 month in a COVID-19 patient. 5 This was also attributed to possible oedema and inflammation associated with COVID-19 illness. 5 However, in our patients, no onycholysis was seen.…”

mentioning

confidence: 99%

“…5 This was also attributed to possible oedema and inflammation associated with COVID-19 illness. 5 However, in our patients, no onycholysis was seen. As three of our patients were not aware of their nail changes, the interval between COVID-19 illness/onset of telogen effluvium and nail manifestations could not be assessed.…”

mentioning

confidence: 99%